Close Menu
A University of Aberdeen researcher has received £105,000 [$208,000] to identify proteins for early-stage colon cancer diagnosis.
 
Pathology professor Graeme Murray will use the funding, from the Association for International Cancer Research, to detect and identify biomarkers for the cancer.
 
Murray said he expects to begin his work in early May, which will use mass spectrometry-based methods. The funding, spread over two years, will be used partly to hire a postdoc to help with the work.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.